These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
320 related items for PubMed ID: 32800223
1. Chronic exposure of human glioblastoma tumors to low concentrations of a pesticide mixture induced multidrug resistance against chemotherapy agents. Doğanlar O, Doğanlar ZB, Kurtdere AK, Chasan T, Ok ES. Ecotoxicol Environ Saf; 2020 Oct 01; 202():110940. PubMed ID: 32800223 [Abstract] [Full Text] [Related]
2. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2. Dai CL, Tiwari AK, Wu CP, Su XD, Wang SR, Liu DG, Ashby CR, Huang Y, Robey RW, Liang YJ, Chen LM, Shi CJ, Ambudkar SV, Chen ZS, Fu LW. Cancer Res; 2008 Oct 01; 68(19):7905-14. PubMed ID: 18829547 [Abstract] [Full Text] [Related]
3. Establishment and biological analysis of the EC109/CDDP multidrug-resistant esophageal squamous cell carcinoma cell line. Wen J, Zheng B, Hu Y, Zhang X, Yang H, Luo KJ, Zhang X, Li YF, Fu JH. Oncol Rep; 2009 Jul 01; 22(1):65-71. PubMed ID: 19513506 [Abstract] [Full Text] [Related]
4. [Correlation of chemosensitivity tested using histoculture drug response assay to expression of multidrug resistance genes and proteins in colorectal cancer tissues]. Yuan SQ, Zhou ZW, Liang YJ, Fu LW, Chen G, Qiu HB, Zhang LY. Ai Zheng; 2009 Sep 01; 28(9):932-8. PubMed ID: 19728910 [Abstract] [Full Text] [Related]
5. Pediatric glioblastoma cell line shows different patterns of expression of transmembrane ABC transporters after in vitro exposure to vinblastine. Valera ET, de Freitas Cortez MA, de Paula Queiroz RG, de Oliveira FM, Brassesco MS, Jabado N, Faury D, Bobola MS, Machado HR, Scrideli CA, Tone LG. Childs Nerv Syst; 2009 Jan 01; 25(1):39-45. PubMed ID: 18946672 [Abstract] [Full Text] [Related]
6. Overexpression of ATP-binding cassette transporter ABCG2 as a potential mechanism of acquired resistance to vemurafenib in BRAF(V600E) mutant cancer cells. Wu CP, Sim HM, Huang YH, Liu YC, Hsiao SH, Cheng HW, Li YQ, Ambudkar SV, Hsu SC. Biochem Pharmacol; 2013 Feb 01; 85(3):325-34. PubMed ID: 23153455 [Abstract] [Full Text] [Related]
7. Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters. Fan YF, Zhang W, Zeng L, Lei ZN, Cai CY, Gupta P, Yang DH, Cui Q, Qin ZD, Chen ZS, Trombetta LD. Cancer Lett; 2018 May 01; 421():186-198. PubMed ID: 29331420 [Abstract] [Full Text] [Related]
8. Increased JNK1 signaling pathway is responsible for ABCG2-mediated multidrug resistance in human colon cancer. Zhu MM, Tong JL, Xu Q, Nie F, Xu XT, Xiao SD, Ran ZH. PLoS One; 2012 May 01; 7(8):e41763. PubMed ID: 22870247 [Abstract] [Full Text] [Related]
9. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function. Teng YN, Sheu MJ, Hsieh YW, Wang RY, Chiang YC, Hung CC. Phytomedicine; 2016 Mar 15; 23(3):316-23. PubMed ID: 26969385 [Abstract] [Full Text] [Related]
10. Melatonin-induced methylation of the ABCG2/BCRP promoter as a novel mechanism to overcome multidrug resistance in brain tumour stem cells. Martín V, Sanchez-Sanchez AM, Herrera F, Gomez-Manzano C, Fueyo J, Alvarez-Vega MA, Antolín I, Rodriguez C. Br J Cancer; 2013 May 28; 108(10):2005-12. PubMed ID: 23632480 [Abstract] [Full Text] [Related]
11. Multidrug resistant lncRNA profile in chemotherapeutic sensitive and resistant ovarian cancer cells. Xu J, Wu J, Fu C, Teng F, Liu S, Dai C, Shen R, Jia X. J Cell Physiol; 2018 Jun 28; 233(6):5034-5043. PubMed ID: 29219179 [Abstract] [Full Text] [Related]
12. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment. Pérez-Tomás R. Curr Med Chem; 2006 Jun 28; 13(16):1859-76. PubMed ID: 16842198 [Abstract] [Full Text] [Related]
13. SIS3, a specific inhibitor of Smad3 reverses ABCB1- and ABCG2-mediated multidrug resistance in cancer cell lines. Wu CP, Murakami M, Hsiao SH, Liu TC, Yeh N, Li YQ, Hung TH, Wu YS, Ambudkar SV. Cancer Lett; 2018 Oct 01; 433():259-272. PubMed ID: 30026175 [Abstract] [Full Text] [Related]
14. Voruciclib, a Potent CDK4/6 Inhibitor, Antagonizes ABCB1 and ABCG2-Mediated Multi-Drug Resistance in Cancer Cells. Gupta P, Zhang YK, Zhang XY, Wang YJ, Lu KW, Hall T, Peng R, Yang DH, Xie N, Chen ZS. Cell Physiol Biochem; 2018 Oct 01; 45(4):1515-1528. PubMed ID: 29486476 [Abstract] [Full Text] [Related]
15. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes. To KKW, Wu X, Yin C, Chai S, Yao S, Kadioglu O, Efferth T, Ye Y, Lin G. J Ethnopharmacol; 2017 May 05; 203():110-119. PubMed ID: 28363522 [Abstract] [Full Text] [Related]
16. Revisiting the role of ABC transporters in multidrug-resistant cancer. Robey RW, Pluchino KM, Hall MD, Fojo AT, Bates SE, Gottesman MM. Nat Rev Cancer; 2018 Jul 05; 18(7):452-464. PubMed ID: 29643473 [Abstract] [Full Text] [Related]
17. Hedgehog signaling regulates drug sensitivity by targeting ABC transporters ABCB1 and ABCG2 in epithelial ovarian cancer. Chen Y, Bieber MM, Teng NN. Mol Carcinog; 2014 Aug 05; 53(8):625-34. PubMed ID: 23423781 [Abstract] [Full Text] [Related]
18. Reversing agents for ATP-binding cassette (ABC) transporters: application in modulating multidrug resistance (MDR). Lee CH. Curr Med Chem Anticancer Agents; 2004 Jan 05; 4(1):43-52. PubMed ID: 14754411 [Abstract] [Full Text] [Related]
19. Icariin enhances cytotoxicity of doxorubicin in human multidrug-resistant osteosarcoma cells by inhibition of ABCB1 and down-regulation of the PI3K/Akt pathway. Wang Z, Yang L, Xia Y, Guo C, Kong L. Biol Pharm Bull; 2015 Jan 05; 38(2):277-84. PubMed ID: 25747987 [Abstract] [Full Text] [Related]
20. Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2. Dai CL, Liang YJ, Wang YS, Tiwari AK, Yan YY, Wang F, Chen ZS, Tong XZ, Fu LW. Cancer Lett; 2009 Jun 28; 279(1):74-83. PubMed ID: 19232821 [Abstract] [Full Text] [Related] Page: [Next] [New Search]